fr 900482 has been researched along with mitomycin in 7 studies
Studies (fr 900482) | Trials (fr 900482) | Recent Studies (post-2010) (fr 900482) | Studies (mitomycin) | Trials (mitomycin) | Recent Studies (post-2010) (mitomycin) |
---|---|---|---|---|---|
29 | 0 | 4 | 12,893 | 1,738 | 2,808 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirai, O; Kikuchi, H; Matsumoto, S; Mizota, T; Mori, J; Shimomura, K | 1 |
Rajski, SR; Rollins, SB; Williams, RM | 1 |
Beckerbauer, L; Cullison, J; Reeves, R; Tepe, JJ; Williams, RM | 1 |
Colandrea, VJ; Jimenez, LS; Rajaraman, S | 1 |
Chamberland, S; Gubler, DA; Namiki, H; Williams, RM | 1 |
Chamberland, S; Grüschow, S; Sherman, DH; Williams, RM | 1 |
Bass, PD; Gubler, DA; Judd, TC; Williams, RM | 1 |
1 review(s) available for fr 900482 and mitomycin
Article | Year |
---|---|
Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approaches.
Topics: Chemistry Techniques, Synthetic; Drug Resistance, Bacterial; Mitomycin; Mitomycins; Oxazines; Streptomyces | 2013 |
6 other study(ies) available for fr 900482 and mitomycin
Article | Year |
---|---|
A new antitumor antibiotic, FR-900482. IV. Hematological toxicity in mice.
Topics: Animals; Antibiotics, Antineoplastic; Blood Cell Count; Bone Marrow Cells; Bridged Bicyclo Compounds; Colony-Forming Units Assay; Female; Hematopoiesis; Hematopoietic Stem Cells; Mice; Mitomycin; Mitomycins; Oxazines; Platelet Count; Spleen | 1987 |
FR900482, a close cousin of mitomycin C that exploits mitosene-based DNA cross-linking.
Topics: Alkylation; Antibiotics, Antineoplastic; Base Sequence; Deoxyribonucleases, Type II Site-Specific; DNA; DNA Adducts; DNA Footprinting; Isomerism; Mass Spectrometry; Mitomycin; Models, Molecular; Molecular Sequence Data; Oxazines | 1997 |
FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Cell Division; Cross-Linking Reagents; DNA; DNA-Binding Proteins; High Mobility Group Proteins; Histocytochemistry; HMGA1a Protein; Humans; Jurkat Cells; Mitomycin; Models, Molecular; Molecular Sequence Data; Molecular Structure; Necrosis; Oncogene Proteins; Oxazines; Phosphoproteins; Precipitin Tests; Protein Structure, Tertiary; Substrate Specificity; Transcription Factors | 2000 |
Synthesis of the mitomycin and FR900482 ring systems via dimethyldioxirane oxidation.
Topics: Indicators and Reagents; Mitomycin; Nucleic Acid Synthesis Inhibitors; Oxazines; Oxidation-Reduction; Stereoisomerism | 2003 |
Synthetic and biosynthetic studies on FR900482 and mitomycin C: an efficient and stereoselective hydroxymethylation of an advanced benzazocane intermediate.
Topics: Antineoplastic Agents; Azo Compounds; Methylation; Mitomycin; Oxazines; Stereoisomerism | 2007 |
Synthesis of potential early-stage intermediates in the biosynthesis of FR900482 and mitomycin C.
Topics: Antibiotics, Antineoplastic; Mitomycin; Molecular Structure; Oxazines; Stereoisomerism; Streptomyces | 2009 |